A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Clinical trial NCT07173244 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07173244
- Sponsor
- Tianjin First Central Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-15
- Primary completion
- 2027-09-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.